Aberdeen Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Aberdeen Group's GSK Position: Q3 2026 in Review
Aberdeen Group opened a new position in GSK (GSK) in Q3 2026: 583,300 shares worth $28.1M. The stake represents 0.04% of the portfolio and ranks #339 among its holdings. This is a return to the name: Aberdeen Group previously reported a position in GSK as recently as Q1 2024.
Aberdeen Group first reported a position in GSK in Q2 2019 and has held it in 6 quarters since. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Aberdeen Group held 583,300 shares of GSK worth $28.1M as of Q3 2026.
- GSK was a new Aberdeen Group position in Q3 2026.
- GSK made up 0.04% of Aberdeen Group's portfolio in Q3 2026, its #339 holding.
- Aberdeen Group first reported a position in GSK in Q2 2019 and has held it in 6 quarters since.
- 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Aberdeen Group's 13F filing for Q3 2026, filed 6 Nov 2026.